Kiniksa Pharmaceuticals International, plc Royalty Expense
Kiniksa Pharmaceuticals International, plc (KNSA) reported Royalty Expense of $835.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2022-02-24
- Kiniksa Pharmaceuticals International, plc royalty expense for fiscal 2021 was $835.00K.
| Period end | Royalty Expense 12 month |
|---|---|
| 2021-12-31 | $835.00K 10-K · filed 2022-02-24 |